Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Kaye

Showing results (91-100 of 136) with videos related to

Pageof 14
Sort By:
The American Journal of Pathology|August 7, 2002
A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infectionChristian R Engwerda, Manabu Ato, Sara E J Cotterell, et al.
EMBO Reports|March 6, 2019
miR-132 suppresses transcription of ribosomal proteins to promote protective Th1 immunityJames P Hewitson, Kunal M Shah, Najmeeyah Brown, et al.
Vaccine|July 9, 2016
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceWayne Paes, Naj Brown, Andrzej M Brzozowski, et al.
Lung|September 16, 2024
Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in SarcoidosisSimon D Fraser, Susannah Thackray-Nocera, Caroline Wright, et al.
Ebiomedicine|May 4, 2020
Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIVWim Adriaensen, Bart Cuypers, Carlota F Cordero, et al.
Frontiers in Immunology|April 12, 2018
Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based ModelingDaniel Moyo, Lynette Beattie, Paul S Andrews, et al.
Plos Pathogens|August 23, 2012
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasisBenjamin M J Owens, Lynette Beattie, John W J Moore, et al.
Plos Neglected Tropical Diseases|November 8, 2024
Clinical anemia predicts dermal parasitism and reservoir infectiousness during progressive visceral leishmaniosisMax C Waugh, Karen I Cyndari, Tom J Lynch, et al.
The Journal of Clinical Investigation|March 18, 2010
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in miceJane E Dalton, Asher Maroof, Benjamin M J Owens, et al.
Frontiers in Immunology|August 25, 2022
Mass spectrometry imaging identifies altered hepatic lipid signatures during experimental <i>Leishmania donovani</i> infectionRoel Tans, Shoumit Dey, Nidhi Sharma Dey, et al.
Pageof 14

Showing results (91-100 of 136) with videos related to

Sort By:
Pageof 14
The American Journal of Pathology|August 7, 2002
A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infectionChristian R Engwerda, Manabu Ato, Sara E J Cotterell, et al.
EMBO Reports|March 6, 2019
miR-132 suppresses transcription of ribosomal proteins to promote protective Th1 immunityJames P Hewitson, Kunal M Shah, Najmeeyah Brown, et al.
Vaccine|July 9, 2016
Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in miceWayne Paes, Naj Brown, Andrzej M Brzozowski, et al.
Lung|September 16, 2024
Effects of Azithromycin on Blood Inflammatory Gene Expression and Cytokine Production in SarcoidosisSimon D Fraser, Susannah Thackray-Nocera, Caroline Wright, et al.
Ebiomedicine|May 4, 2020
Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIVWim Adriaensen, Bart Cuypers, Carlota F Cordero, et al.
Frontiers in Immunology|April 12, 2018
Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based ModelingDaniel Moyo, Lynette Beattie, Paul S Andrews, et al.
Plos Pathogens|August 23, 2012
IL-10-producing Th1 cells and disease progression are regulated by distinct CD11c⁺ cell populations during visceral leishmaniasisBenjamin M J Owens, Lynette Beattie, John W J Moore, et al.
Plos Neglected Tropical Diseases|November 8, 2024
Clinical anemia predicts dermal parasitism and reservoir infectiousness during progressive visceral leishmaniosisMax C Waugh, Karen I Cyndari, Tom J Lynch, et al.
The Journal of Clinical Investigation|March 18, 2010
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in miceJane E Dalton, Asher Maroof, Benjamin M J Owens, et al.
Frontiers in Immunology|August 25, 2022
Mass spectrometry imaging identifies altered hepatic lipid signatures during experimental <i>Leishmania donovani</i> infectionRoel Tans, Shoumit Dey, Nidhi Sharma Dey, et al.
Pageof 14